Anthony Stephen O'Brien - 12 May 2021 Form 4 Insider Report for Evofem Biosciences, Inc. (EVFM)

Role
Director
Signature
/s/ Justin J. File, attorney-in-fact
Issuer symbol
EVFM
Transactions as of
12 May 2021
Net transactions value
$0
Form type
4
Filing time
13 May 2021, 16:14:07 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVFM Common Stock Award $0 +90,000 $0.000000 90,000 12 May 2021 Common Stock 90,000 $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2021. The option was awarded in connection with Mr. O'Brien's board and committee services.